The special authority and Hospital Medicines List restriction were removed from 1 March 2016 (Pharmac). This is recommended first-line treatment.
Treatment of First Episode Genital Herpes
Oral valaciclovir 500mg bd for 7/7 or longer if new lesions appear during treatment or healing is incomplete.
Immunocompromised patients consider valaciclovir 1g bd for 7–10 days.
Alternative: oral aciclovir 400mg 3 times daily (8 hourly) for 7 days.
Treatment of Recurrent Genital Herpes
Oral valaciclovir 500mg bd for 3/7.
Alternative: oral aciclovir 800mg 3 times daily for 2 days.
Prescribe enough tablets for patients to be able to self-initiate treatment at the onset of symptoms.
Only recommended for people with HSV confirmed on testing. Given daily to prevent recurrences and reduce asymptomatic shedding. Suggest prescribing for 12 months, followed by a break of 3 months to see if recurrences are still frequent and/or bothersome.
Oral valaciclovir 500mg daily (increase to 500mg BD on an individual basis of clinical presentation and/or having breakthrough recurrences on 500mg daily).
The Guidelines are a consensus opinion of the STIEF Professional Advisory Board (PAB). The PAB has representation from nationwide medical, nursing and allied disciplines involved in the management of STIs. The Guidelines are produced by considering available literature, both New Zealand wide and international, and by basing the medical recommendations on the evidence in the literature or reasonable supposition and opinions of medical experts.